ELAC2/HPC2 polymorphisms, prostate-specific antigen levels, and prostate cancer.
Severi G, Giles GG, Southey MC, Tesoriero A, Tilley W, Neufing P, Morris H, English DR, McCredie MR, Boyle P, Hopper JL.
Severi G, et al.
J Natl Cancer Inst. 2003 Jun 4;95(11):818-24. doi: 10.1093/jnci/95.11.818.
J Natl Cancer Inst. 2003.
PMID: 12783937